During the past decade, Hospital de Galdakao conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 7 clinical trials were completed, i.e. on average, 11.5% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 3 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Galdakao" #1 sponsor was "Hospital Galdakao-Usansolo" with 12 trials, followed by "PETHEMA Foundation" with 9 trials sponsored, "Boehringer Ingelheim" with 7 trials sponsored, "Fundación EPIC" with 4 trials sponsored and "Terumo Europe N.V." with 4 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Galdakao" #1 collaborator was "Instituto de Salud Carlos III" with 5 trials as a collaborator, "Gilead Sciences" with 4 trials as a collaborator, "Dynamic Science S.L." with 3 trials as a collaborator, "Hospital Costa del Sol" with 3 trials as a collaborator and "Hospital Donostia" with 2 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Galdakao" are "Coronary Artery Disease" (6 trials), "Inflammatory Bowel Diseases" (4 trials), "Ulcerative Colitis" (4 trials), "Acute Lymphoblastic Leukemia" (3 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Hospital de Galdakao" in a lesser frequency.

Most popular intervention types in "Hospital de Galdakao" are "Drug" (43 trials), "Device" (12 trials), "Other" (11 trials), "Procedure" (8 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Prednisone" (3 trials), "Atrasentan" (2 trials), "BIS monitor" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Galdakao" are 82 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Galdakao". undefined are not yet recruiting, 16 are recruiting, 6 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 50 completed trials in Hospital de Galdakao, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Galdakao, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 15 trials that are defined as “Not Applicable".